Literature DB >> 10852369

Somatic segregation errors predominantly contribute to the gain or loss of a paternal chromosome leading to uniparental disomy for chromosome 15.

W P Robinson1, S L Christian, B D Kuchinka, M S Peñaherrera, S Das, S Schuffenhauer, S Malcolm, A A Schinzel, T J Hassold, D H Ledbetter.   

Abstract

Paternal uniparental disomy (UPD) for chromosome 15 (UPD15), which is found in approximately 2% of Angelman syndrome (AS) patients, is much less frequent than maternal UPD15, which is found in 25% of Prader-Willi syndrome patients. Such a difference cannot be easily accounted for if 'gamete complementation' is the main mechanism leading to UPD. If we assume that non-disjunction of chromosome 15 in male meiosis is relatively rare, then the gain or loss of the paternal chromosome involved in paternal and maternal UPD15, respectively, may be more likely to result from a post-zygotic rather than a meiotic event. To test this hypothesis, the origin of the extra chromosome 15 was determined in 21 AS patients with paternal UPD15 with a paternal origin of the trisomy. Only 4 of 21 paternal UPD15 cases could be clearly attributed to a meiotic error. Furthermore, significant non-random X-chromosome inactivation (XCI) observed in maternal UPD15 patients (p < 0.001) provides indirect evidence that a post-zygotic error is also typically involved in loss of the paternal chromosome. The mean maternal and paternal ages of 33.4 and 39.4 years, respectively, for paternal UPD15 cases are increased as compared with normal controls. This may be simply the consequence of an age association with maternal non-disjunction leading to nullisomy for chromosome 15 in the oocyte, although the higher paternal age in paternal UPD15 as compared with maternal UPD15 cases is suggestive that paternal age may also play a role in the origin of paternal UPD15.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852369     DOI: 10.1034/j.1399-0004.2000.570505.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Epigenetics and assisted reproductive technology: a call for investigation.

Authors:  Emily L Niemitz; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2004-02-27       Impact factor: 11.025

Review 2.  Angelman syndrome (AS, MIM 105830).

Authors:  Griet Van Buggenhout; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2009-05-20       Impact factor: 4.246

3.  X-chromosome inactivation patterns in females with Prader-Willi syndrome.

Authors:  Merlin G Butler; Mariana F Theodoro; Douglas C Bittel; Paul J Kuipers; Daniel J Driscoll; Zohreh Talebizadeh
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

4.  Molecular and Clinical Aspects of Angelman Syndrome.

Authors:  A Dagli; K Buiting; C A Williams
Journal:  Mol Syndromol       Date:  2011-07-28

Review 5.  Angelman syndrome and melatonin: What can they teach us about sleep regulation.

Authors:  Daniella Buonfiglio; Daniel L Hummer; Ariel Armstrong; John Christopher Ehlen; Jason P DeBruyne
Journal:  J Pineal Res       Date:  2020-10-11       Impact factor: 13.007

Review 6.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

Review 7.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

Review 8.  Tyrosinemia type 1 and Angelman syndrome due to paternal uniparental isodisomy 15.

Authors:  Irene Ferrer-Bolufer; Jaime Dalmau; Ramiro Quiroga; Silvestre Oltra; Carmen Orellana; Sandra Monfort; Mónica Roselló; Alberto De La Osa; Francisco Martinez
Journal:  J Inherit Metab Dis       Date:  2009-12-23       Impact factor: 4.982

Review 9.  Human pre-implantation embryo development.

Authors:  Kathy K Niakan; Jinnuo Han; Roger A Pedersen; Carlos Simon; Renee A Reijo Pera
Journal:  Development       Date:  2012-03       Impact factor: 6.868

10.  Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.

Authors:  M Febin Farook; Michael DeCuypere; Keith Hyland; Toru Takumi; Mark S LeDoux; Lawrence T Reiter
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.